Two distinct cancer predisposition syndromes are associated with MMR deficient cancers, caused by germline pathogenic variants (PV) affecting one of four MMR genes, MLH1 (MIM *120436), MSH2 (MIM *609309), MSH6 (MIM *600678), or PMS2 (MIM *600259). This evidence concerns the gene MSH2 and cancer.